Johnson & Johnson’s most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $125.00 short put and a strike $120.00 long put offers a potential 9.65% return on risk over the next 3 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $125.00 by expiration. The full premium credit of $0.44 would be kept by the premium seller. The risk of $4.56 would be incurred if the stock dropped below the $120.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.
The RSI indicator is at 62.06 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
Johnson & Johnson Ordered to Pay $4.69 Billion in Cancer Case
Fri, 13 Jul 2018 23:55:00 +0000
This is the sixth-largest product-defect award in U.S. history.
Jim Cramer: This Market Isn’t Done Going Higher
Fri, 13 Jul 2018 23:01:00 +0000
We aren’t done moving higher even with the president ready to strike at a moment’s notice against any of our allies.
Johnson & Johnson still battling thousands of cases involving its baby powder
Fri, 13 Jul 2018 22:55:54 +0000
A jury has awarded nearly $4.7 billion in damages to a group of women who said Johnson & Johnson talcum products caused them to develop ovarian cancer. But the company is still facing thousands of cases involving its baby powder. CBS News national correspondent Jericka Duncan reports.
Why Johnson & Johnson, Cisco Systems, and Ingredion Slumped Today
Fri, 13 Jul 2018 21:28:00 +0000
From a multibillion-dollar verdict to disappointing quarterly results and new competitive threats, these three companies lagged the broader market today.
Why J&J Investors Aren’t So Concerned About $4.69B Talc Verdict
Fri, 13 Jul 2018 21:11:20 +0000
Jul.13 — Johnson & Johnson should ready itself for a flood of new lawsuits after a jury ordered the company to pay $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in its talc products, legal experts said. Bloomberg’s Max Nisen has more on “What’d You Miss?”
Follow Us on Facebook